AMLX vs BIIB: Which Stock is Better?
Side-by-side comparison of Amylyx Pharmaceuticals Inc and Biogen Inc in 2026
AMLX
Amylyx Pharmaceuticals Inc
$14.29
BIIB
Biogen Inc
$185.29
Key Metrics Comparison
| Metric | AMLX | BIIB | Winner |
|---|---|---|---|
| Market Cap | $1.59B | $27.19B | BIIB |
| P/E Ratio | N/A | 21.10 | BIIB |
| EPS (TTM) | $N/A | $8.78 | BIIB |
| Revenue Growth | -1.0% | -0.1% | BIIB |
| Gross Margin | 13594.6% | 78.9% | AMLX |
Analyze AMLX
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is AMLX or BIIB a better investment?
Comparing AMLX and BIIB: Amylyx Pharmaceuticals Inc has a market cap of $1.59B while Biogen Inc has $27.19B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between AMLX and BIIB?
AMLX (Amylyx Pharmaceuticals Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: AMLX or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: AMLX or BIIB?
BIIB has higher revenue growth at -0.1% vs -1.0% for AMLX.
Which company is more profitable: AMLX or BIIB?
Amylyx Pharmaceuticals Inc (AMLX) has higher gross margins at 13594.6% compared to 78.9% for BIIB.
Which is the larger company: AMLX or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $27.19B compared to $1.59B for AMLX.
Should I buy AMLX or BIIB in 2026?
Both AMLX and BIIB have investment merit. AMLX trades at $14.29 while BIIB trades at $185.29. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between AMLX and BIIB stock?
Key differences: Market Cap ($1.59B vs $27.19B), P/E Ratio (N/A vs 21.1x), Revenue Growth (-1.0% vs -0.1%), Gross Margin (13594.6% vs 78.9%).